医学
病态的
甲状腺癌
表型
肥胖
甲状腺乳突癌
甲状腺
癌症
肿瘤科
内科学
病理
基因
遗传学
生物
作者
Xiuyun Li,Xiujuan Zhang,Li Sun,Lulu Yang,Qihang Li,Zhixiang Wang,Yafei Wu,Ling Gao,Jiajun Zhao,Qingling Guo,Meng Zhou
标识
DOI:10.1016/j.eprac.2024.04.010
摘要
ABSTRACT
Background
The association between obesity, metabolic dysregulation, and the aggressive pathological traits of papillary thyroid carcinoma (PTC) continues to be a contentious issue. To date, no investigations have examined the impact of metabolic status on the malignant pathological features of PTC in relation to obesity. Methods
This research involved 855 adult PTC patients from Shandong Provincial Hospital, classified into four groups based on metabolic and obesity status: metabolically healthy nonobese (MHNO), metabolically unhealthy nonobese (MUNO), metabolically healthy obese (MHO), and metabolically unhealthy obese (MUO). We employed logistic regression to investigate the relationship between these metabolic obesity phenotypes and PTC's pathological characteristics. Mediation analysis was also performed to determine metabolic abnormalities' mediating role in the nexus between obesity and these characteristics. Results
Relative to MHNO individuals, the MUO group was significantly associated with an elevated risk of larger tumor sizes and a greater number of tumor foci in PTC. Mediation analysis indicated that obesity directly influences tumor size, whereas its effect on tumor multifocality is mediated through metabolic dysfunctions. Specifically, HDL-C levels were notably associated with tumor multifocality within obese subjects, serving as a mediator in obesity's impact on this trait. Conclusion
The concurrent presence of obesity and metabolic dysregulation is often connected to more aggressive pathological features in PTC. The mediation analysis suggests obesity directly affects tumor size and indirectly influences tumor multifocality via low HDL-C levels.
科研通智能强力驱动
Strongly Powered by AbleSci AI